Free Trial
NASDAQ:CRVL

CorVel Q2 2025 Earnings Report

CorVel logo
$61.75 0.00 (0.00%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$61.76 +0.01 (+0.02%)
As of 05/29/2026 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CorVel EPS Results

Actual EPS
$0.45
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

CorVel Revenue Results

Actual Revenue
$224.38 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

CorVel Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, November 5, 2024
Conference Call Time
6:00AM ET

Upcoming Earnings

CorVel's Q1 2027 earnings is estimated for Tuesday, August 4, 2026, based on past reporting schedules, with a conference call scheduled on Friday, July 31, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

CorVel Earnings Headlines

CorVel (NASDAQ:CRVL) Upgraded by Wall Street Zen to "Buy" Rating
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
CorVel (NASDAQ:CRVL) Shares Gap Down - Time to Sell?
See More CorVel Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CorVel? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CorVel and other key companies, straight to your email.

About CorVel

CorVel (NASDAQ:CRVL) Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs). CorVel also offers case management, utilization review, and settlement solutions designed to accelerate claim resolution. Its technology framework leverages predictive modeling and benchmarking to flag potential cost drivers, helping clients optimize clinical and financial performance.

Founded in 1987 and headquartered in Irvine, California, CorVel has expanded its footprint across the United States, serving insurance carriers, third-party administrators, self-insured employers, and government entities. Over the years, the company has invested in research and development to enhance its cloud-based service delivery and to integrate mobile tools that support remote assessments and digital provider collaboration.

Under the leadership of President and Chief Executive Officer Thomas F. Ryan, CorVel continues to focus on innovation in healthcare technology and risk management. The senior management team combines expertise in insurance operations, healthcare administration, and software engineering to advance the company’s mission of simplifying complex claims processes and delivering actionable insights for better client and patient outcomes.

View CorVel Profile